Application Progress of Human Epididymis Protein 4 in Ovarian Cancer

Yuan SHI,Shu-hua ZHAO,Ling ZHANG,Lu GAO,Hong YANG
DOI: https://doi.org/10.13241/j.cnki.pmb.2017.02.045
2017-01-01
Abstract:Ovarian cancer,a commom femal malignant cancer,is the leading cause of death among gynecologic cancers.The early diagnosis make a contribute to improve the 5-year survival rate.Human epididymis protein 4 (HE4).A novel ovarian cancer marker,belonged to the family of protease inhibitor.HE4 is overexpressed in the tissue of ovarian tumor and serum of patients.HE4 has higher sensitivity and specificity than cancer antigen 125 (CA125) in early diagnosis of ovarian cancer,and is a better predictor for optimal cytoreduction and platinum response during primary treatment.HE4 may have a great clinical value for detecting recurrences and monitoring the prognosis of ovarian cancer.
What problem does this paper attempt to address?